Cover; Title page; Contents; Introduction; Targeting the estrogen receptor in clinical breast cancer; HER-2/Neu signaling and therapeutic approaches in breast cancer; Farnesyltransferase inhibitors: Potential therapeutic for inflammatory breast cancer?; Role of cell cycle control and cyclin-dependent kinases in breast cancer; Heat shock protein 90 is a rational molecular target in breast cancer; The proteasome as a novel target for the treatment of breast cancer; Apoptosis and the treatment of breast cancer; Immunologic targets for breast cancer.
0
This work is devoted to therapies that take advantage of molecular targets relevant to breast cancer - so called novel molecular therapies. It presents a sampling of both old and new molecularly targeted therapies that are being developed.